Pelvic Floor Exercises in Patients With Sjögren's

Status Completed

Clinical Trial Summary

When the literature is examined, the positive effects of pelvic floor exercises on sexual functions have been supported by studies. However, the effectiveness of pelvic floor exercises on pelvic floor problems in women with sjögren has not been examined in the literature. The aim of this study is in order to examine the effect of pelvic floor exercises on sexual function in women with primer Sjögren Syndrome (pSS), since these negativities affect both the quality of life and sexual functions in women with pSS. This is a randomized controlled trial examining the effect of 8 weeks of home-based pelvic floor exercises on pain, sexual dysfunction and quality of life on women with sjogren's.

Clinical Trial Description

Demographic information form, HAQ, VAS, Pelvic Pain Impact Questionnaire (PPIQ), Pelvic Floor Distress Scale-20, Female Sexual Function Inventory (FSFI), Pelvic Floor Impact Questionnaire (PFIQ-7) will be applied to female patients with Sjögren's who meet the inclusion criteria.After the initial evaluation, patients will be randomized to intervention and control groups. The intervention group will be taught home exercises including fast and slow contraction and keeping the muscles around the pelvic floor in different positions (sitting, standing, lying) and will be asked to do them every day for 8 weeks according to the determined protocol. For eight weeks, the patients will be supported by the phone by the physiotherapist and at the same time, they will be checked whether they do the exercises. The control group will be given training on pelvic floor anatomy. At the end of eight weeks, patients will be given a final evaluation and the results will be analyzed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05079581
Study type	Interventional
Source	Akdeniz University
Contact
Status	Completed
Phase	N/A
Start date	October 15, 2021
Completion date	August 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02752269` - Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome
Completed	`NCT03905525` - Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome	Phase 2
Completed	`NCT04819269` - Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome	Phase 3
Completed	`NCT02011776` - A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome	N/A
Completed	`NCT03762824` - Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease	Phase 4
Terminated	`NCT04035668` - A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome	Phase 2
Completed	`NCT02049112` - A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study	Phase 4
Recruiting	`NCT04848870` - Dental and Periodontal Status of Patients With Sjögren's Syndrome.
Completed	`NCT03941184` - Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Completed	`NCT03608761` - Comparison Between Rebamipide 2% Versus Autologous Serum	Phase 4
Active, not recruiting	`NCT04793646` - N-acetylcysteine for Primary Sjögren's Syndrome	N/A